Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis
Filipe Seguro Paula,1 José Delgado Alves1,2 1Immunomediated Systemic Diseases Unit, Department of Medicine 4, Fernando Fonseca Hospital, Amadora, 2Center for the Study of Chronic Diseases, Department of Pharmacology, Faculty of Medical Sciences, Lisbon, Portugal Abstract: The way rheumato...
Guardado en:
Autores principales: | Paula FS, Delgado Alves J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/983fbd9ba1f64aeb8a6a7d7068c7a5f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka T, et al.
Publicado: (2014) -
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
por: A. A. Alshevskaya, et al.
Publicado: (2012) -
Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate
por: O’Dell JR, et al.
Publicado: (2018) -
Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
por: Fischer PA, et al.
Publicado: (2018)